Research
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1966 (Published 22 May 2020) Cite this as: BMJ 2020;369:m1966Linked Editorial
Covid-19 related hospital admissions in the United States
Data supplement
Web extra
- Data Supplement - Web appendix: Supplementary material
Related articles
- Editorial Published: 27 May 2020; BMJ 369 doi:10.1136/bmj.m2082
- Editorial Published: 10 June 2020; BMJ 369 doi:10.1136/bmj.m2237
- Research Published: 15 December 2020; BMJ 371 doi:10.1136/bmj.m4677
- Clinical Review Published: 10 March 2021; BMJ 372 doi:10.1136/bmj.n436
- Editorial Published: 07 April 2021; BMJ 373 doi:10.1136/bmj.n898
- Research Published: 14 October 2021; BMJ 375 doi:10.1136/bmj.n2400
- Research Published: 23 March 2022; BMJ 376 doi:10.1136/bmj-2021-068585
See more
- US women must be told breast density after mammogram, says FDABMJ September 18, 2024, 386 q2045; DOI: https://doi.org/10.1136/bmj.q2045
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Microdosing mushroom sweet treats are recalled in US after six hospital admissions and two potential deathsBMJ August 27, 2024, 386 q1871; DOI: https://doi.org/10.1136/bmj.q1871
- Over-the-counter painkillers may not be sufficient when fitting IUDs, says US agencyBMJ August 19, 2024, 386 q1820; DOI: https://doi.org/10.1136/bmj.q1820
- Michael Bloomberg donates $600m to historically black US medical schoolsBMJ August 08, 2024, 386 q1766; DOI: https://doi.org/10.1136/bmj.q1766
Cited by...
- Severe disease is not essential for a high neutralizing antibody response post-SARS-CoV-2 infection
- Use of chronic medications and risk of death due to COVID-19 in hospitalised patients
- Artificial Intelligence (AI) Based Prediction of Mortality, ICU Admission and Ventilation Support Requirement for COVID-19 Patients Using 122 Clinical and Demographic Parameters
- Risk Factors and Outcomes Associated With Re-Intubation Secondary to Respiratory Failure in Patients With COVID-19 ARDS
- SARS-CoV-2 in an immunocompromised host: convalescent plasma therapy and viral evolution elucidated by whole genome sequencing
- Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework
- Assessing the Risk of Stroke in the Elderly in the Context of Long-COVID, Followed Through the Lens of Family Medicine
- Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial
- C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR trial
- Biological risk in Italian prisons: data analysis from the second to the fourth wave of COVID-19 pandemic
- Home monitoring by pulse oximetry of primary care patients with COVID-19: a pilot randomised controlled trial
- Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center run by Medecins sans Frontieres in Herat, Afghanistan
- Home monitoring by pulse oximetry of primary care patients with COVID-19: a pilot randomised controlled trial
- Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients
- Hospitalised COVID-19 outcomes are predicted by hypoxaemia and pneumonia phenotype irrespective of the timing of their emergence
- Predictors of in-hospital mortality in critically ill patients with COVID-19: a large dual tertiary centre study
- Population pharmacokinetics and exposure-response analysis of sotrovimab in the early treatment of COVID-19
- Intubation Timing in COVID-19 Based on ROX Index and Association With Patient Outcomes
- Healthcare system overstretch and in-hospital mortality of intubated COVID-19 patients in Greece: an updated analysis, September 2020 to April 2022
- Rationale, Design, and Baseline Characteristics of the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) Cohort
- Early COVID-19 respiratory risk stratification using machine learning
- Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large metropolitan region
- Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
- Prognostic value of National Early Warning Scores (NEWS2) and component physiology in hospitalised patients with COVID-19: a multicentre study
- Long COVID in Cancer patients: Preponderance of Symptoms in Majority of Patients over Long Time Period
- C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR trial
- Treatment Decision Making for Older Kidney Patients during COVID-19
- Pandemic inequity in a megacity: a multilevel analysis of individual, community and healthcare vulnerability risks for COVID-19 mortality in Jakarta, Indonesia
- cfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infections in general practice: a study protocol for a prospective cohort study
- Evaluation of the relationship between the disease severity and the level of physical activity in patients followed up with COVID-19 diagnosis
- Building Medical Rehabilitation System with Safety and Without Interruption for the Patients with Coronavirus Disease 2019 Using the Functional Resonance Analysis Method (FRAM)
- SARS-CoV-2 humoral immune response in patients with cardiovascular risk factors: the COmmunity Cohort Study protocol
- Clinical characteristics of COVID-19 patients admitted to Intensive Care Unit in Panama during the first pandemic wave admissions in 2020
- Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron Variant of Concern
- Combination of Baricitinib plus Remdesivir and Dexamethasone improves time to recovery and mortality among hospitalized patients with severe COVID-19 infection
- Clinical and imaging characteristics of patients with COVID-19 predicting hospital readmission after emergency department discharge: a single-centre cohort study in Italy
- Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: international observational federated study based on electronic health records through the 4CE consortium
- Examining the utility of extended laboratory panel testing in the emergency department for risk stratification of patients with COVID-19: a single-centre retrospective service evaluation
- Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE)
- Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals
- Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with Coronavirus Disease 19 (COVID-19) from the perspective of National Health Service England
- Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
- Performance features and mortality prediction of the 4C Score early in COVID-19 infection: a retrospective study in Saudi Arabia
- Elucidating symptoms of COVID-19 illness in the Arizona CoVHORT: a longitudinal cohort study
- EARLY LENZILUMAB TREATMENT OF COVID-19 PATIENTS USING C-REACTIVE PROTEIN AS A BIOMARKER IMPROVES EFFICACY: RESULTS FROM THE PHASE 3 'LIVE-AIR TRIAL
- Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis
- Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients
- The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis
- Contribution of endogenous and exogenous antibodies to clearance of SARS-CoV-2 during convalescent plasma therapy
- Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study
- Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection
- Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic
- From Epidemic to Pandemic: Comparing Hospital Staff Emotional Experience Between MERS and COVID-19
- COVID-19-Induced New-Onset Diabetes: Trends and Technologies
- Risk factors associated with severe outcomes of COVID-19: A systematic rapid review to inform national guidance on vaccine prioritization in Canada
- Establishing and characterising large COVID-19 cohorts after mapping the Information System for Research in Primary Care in Catalonia to the OMOP Common Data Model
- Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol
- Effect of the Neutralizing SARS-CoV-2 Antibody Sotrovimab in Preventing Progression of COVID-19: A Randomized Clinical Trial
- Prone positioning of patients with moderate hypoxia due to COVID-19: A multicenter pragmatic randomized trial [COVID-PRONE]
- SARS-CoV-2 epidemic after social and economic reopening in three US states reveals shifts in age structure and clinical characteristics
- Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis
- Multi-ethnic Investigation of Risk and Immune Determinants of COVID-19 Outcomes
- Respiratory Mechanics and Association With Inflammation in * COVID-19-Related ARDS
- Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database
- SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19
- Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
- Association between obesity and hospitalization in mild COVID-19 young adult outpatients in Brazil: a prospective cohort study
- Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
- Clinical Benefits and Budget Impact of Lenzilumab plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with COVID-19 in the United States from the Hospital Perspective
- Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults
- Young adults vulnerability to COVID-19 in Brazil: an overview across the country
- Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain
- Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium
- Circulating multimeric immune complexes drive immunopathology in COVID-19
- Efficacy of remdesivir in hospitalised COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan
- Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales
- Do Covid-19 patients needing ICU admission have worse 6 months follow up outcomes when compared with hospitalized non-ICU patients? A prospective cohort study
- Association of body mass index with morbidity in patients hospitalised with COVID-19
- Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe
- Physician visits and medication prescriptions for major chronic diseases during the COVID-19 pandemic in Japan: retrospective cohort study
- Predicting mortality of individual patients with COVID-19: a multicentre Dutch cohort
- Heparin for Moderately Ill Patients with Covid-19
- Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease - a cohort study across eighteen countries
- Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: a population-based register study with implications to vaccinations
- Comorbidity accounts for severe COVID-19 risk, but how do we measure it? Retrospective assessment of the performance of three measures of comorbidity using 4,607 hospitalizations
- Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study
- Common and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity